CD5 positive immunoregulatory B cells in spleen populations from multiple myeloma patients

CD19+CD5+ lymphocytes constitute a minority of peripheral blood B cells. In view of the importance of these cells in the pathogenesis of the immunoregulation of myeloma, their incidence in another lymphoid organ was determined. CD5+ B cells were studied in 9 spleens from patients with multiple myeloma and in 10 spleens from normal individuals removed secondary to trauma. The total number of CD19+ B cells were increased in myeloma spleens (44.4% ± 12.6%) as compared to normal spleens (20.4% ± 7.4%). Likewise, the percentage of CD19 cells which co‐expressed CD5 were increased in myeloma (25.3% ± 12.4%) versus normal (4.4% ± 2.3%) spleen. CD5+ B cells isolated from myeloma spleens, but not normal spleens, inhibit production of immunoglobulin in a pokeweed mitogen driven assay. Thus the spleen appears to be an important source of immunoregulatory B cells in multiple myeloma.